Last 12 months
Inside the activity.
1 purchase rows · 60 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 1 | 6 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 10 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2022 Filed Aug 19, 2022 20:39 UTC |
Torti FrankDirector
|
GrantStock Option (right to buy) · Derivative | 339,296 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000089 · wf-form4_166094156090925.xml · derivative · entry 2 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,296 Underlying: Common Stock · 339,296 shares Expires 2032-08-17 F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:39 UTC |
Torti FrankDirector
|
GrantCommon Stock | 225,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000089 · wf-form4_166094156090925.xml · nonDerivative · entry 1 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,358 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| July 27, 2022 Filed Jul 29, 2022 11:38 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 510 | $4.27 | $2,177.70 |
DisclosureSEC source: 0001764013-22-000078 · wf-form4_165909471978803.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,104 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on July 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| July 27, 2022 Filed Jul 29, 2022 11:36 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 1,528 | $4.27 | $6,524.56 |
DisclosureSEC source: 0001764013-22-000077 · wf-form4_165909456363894.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 552,731 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on July 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 07:35 UTC |
Macias William L.Chief Medical Officer
|
SaleCommon Stock | 322 | $4.70 | $1,513.40 |
DisclosureSEC source: 0001764013-22-000074 · wf-form4_165883529608492.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,626 F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 1,167 of these RSUs vested on July 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 11:05 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 1,376 | $4.02 | $5,531.52 |
DisclosureSEC source: 0001764013-22-000072 · wf-form4_165667352814683.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,259 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on June 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 - $4.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 11:04 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 460 | $4.02 | $1,849.20 |
DisclosureSEC source: 0001764013-22-000071 · wf-form4_165667344261552.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,614 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,136 of these RSUs vested on June 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 - $4.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 24, 2022 Filed May 25, 2022 20:26 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 492 | $3.79 | $1,864.68 |
DisclosureSEC source: 0001764013-22-000047 · wf-form4_165351034511810.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,074 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on May 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.79 - $3.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 24, 2022 Filed May 25, 2022 20:23 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 1,471 | $3.79 | $5,575.09 |
DisclosureSEC source: 0001764013-22-000045 · wf-form4_165351019453934.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,635 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on May 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.79 - $3.82 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 11:08 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 541 | $4.72 | $2,553.52 |
DisclosureSEC source: 0001764013-22-000043 · wf-form4_165123049662918.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,566 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on April 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 - $4.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 11:05 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 1,622 | $4.72 | $7,655.84 |
DisclosureSEC source: 0001764013-22-000041 · wf-form4_165123029015521.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,106 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on April 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 16:34 UTC |
Macias William L.Chief Medical Officer
|
SaleCommon Stock | 1,392 | $4.98 | $6,932.16 |
DisclosureSEC source: 0001764013-22-000039 · wf-form4_165048683626750.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,948 F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 25% of these RSUs vested on April 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| March 24, 2022 Filed Apr 14, 2022 11:18 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 6,381 | $5.90 | $37,647.90 |
DisclosureSEC source: 0001764013-22-000037 · wf-form4_164993512439127.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,107 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 25% of these RSUs vested on March 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| March 24, 2022 Filed Apr 14, 2022 11:16 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 19,227 | $5.90 | $113,439.30 |
DisclosureSEC source: 0001764013-22-000035 · wf-form4_164993497408514.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,728 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 25% of these RSUs vested on March 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| January 28, 2022 Filed Jan 31, 2022 22:01 UTC |
Levine Mark S.Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 383,000 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0001764013-22-000027 · wf-form4_164366644858148.xml · derivative · entry 2 Levine Mark S. · CIK 0001617236 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,000 Underlying: Common Stock · 383,000 shares Expires 2032-01-28 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on January 19, 2023 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 28, 2022 Filed Jan 31, 2022 22:01 UTC |
Levine Mark S.Chief Legal Officer
|
GrantCommon Stock | 143,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000027 · wf-form4_164366644858148.xml · nonDerivative · entry 1 Levine Mark S. · CIK 0001617236 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,000 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on January 19, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:03 UTC |
MIGAUSKY GEORGE VDirector
|
GrantStock Option (right to buy) · Derivative | 71,492 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001764013-22-000019 · wf-form4_164202501508435.xml · derivative · entry 2 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,792 Underlying: Common Stock · 71,492 shares Expires 2032-01-10 F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:03 UTC |
MIGAUSKY GEORGE VDirector
|
GrantCommon Stock | 21,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000019 · wf-form4_164202501508435.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,926 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:13 UTC |
Torti FrankDirector
|
GrantStock Option (right to buy) · Derivative | 329,485 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001764013-22-000023 · wf-form4_164202558772198.xml · derivative · entry 2 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,748 Underlying: Common Stock · 329,485 shares Expires 2032-01-10 F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:13 UTC |
Torti FrankDirector
|
GrantCommon Stock | 100,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000023 · wf-form4_164202558772198.xml · nonDerivative · entry 1 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,726 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:09 UTC |
Fromkin Andrew J.Director
|
GrantStock Option (right to buy) · Derivative | 71,492 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001764013-22-000021 · wf-form4_164202534055827.xml · derivative · entry 2 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,973 Underlying: Common Stock · 71,492 shares Expires 2032-01-10 F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:09 UTC |
Fromkin Andrew J.Director
|
GrantCommon Stock | 21,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000021 · wf-form4_164202534055827.xml · nonDerivative · entry 1 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,426 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:00 UTC |
Hughes Douglas J.Director
|
GrantStock Option (right to buy) · Derivative | 71,492 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001764013-22-000017 · wf-form4_164202480829515.xml · derivative · entry 2 Hughes Douglas J. · CIK 0001710863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,973 Underlying: Common Stock · 71,492 shares Expires 2032-01-10 F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 22:00 UTC |
Hughes Douglas J.Director
|
GrantCommon Stock | 21,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000017 · wf-form4_164202480829515.xml · nonDerivative · entry 1 Hughes Douglas J. · CIK 0001710863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,173 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 21:56 UTC |
Pande AtulDirector
|
GrantStock Option (right to buy) · Derivative | 71,492 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001764013-22-000015 · wf-form4_164202456711747.xml · derivative · entry 3 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,973 Underlying: Common Stock · 71,492 shares Expires 2032-01-10 F4 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 21:56 UTC |
Pande AtulDirector
|
GrantCommon Stock | 21,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000015 · wf-form4_164202456711747.xml · nonDerivative · entry 1 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,926 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 15:58 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 55,318 | $7.25 | $401,055.50 |
DisclosureSEC source: 0001764013-22-000013 · wf-form4_164191666614109.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,488 F1 · security: On August 3, 2021, the holder was granted 285,306 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on August 4, 2021, of which 50% of these RSUs vested on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 15:53 UTC |
Barnett Eva ReneeChief Financial Officer
|
SaleCommon Stock | 29,959 | $7.25 | $217,202.75 |
DisclosureSEC source: 0001764013-22-000011 · wf-form4_164191639600365.xml · nonDerivative · entry 1 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,541 F1 · security: On October 4, 2021, the holder was granted 59,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 5, 2021. These RSUs vested in their entirety on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 15:49 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 125,158 | $7.25 | $907,395.50 |
DisclosureSEC source: 0001764013-22-000009 · wf-form4_164191616856320.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,955 F1 · security: On August 3, 2021, the holder was granted 570,613 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on August 4, 2021, of which 37.5% of these RSUs vested on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 12:39 UTC |
Macias William L.Chief Medical Officer
|
SaleCommon Stock | 26,813 | $8.28 | $222,011.64 |
DisclosureSEC source: 0001764013-22-000004 · wf-form4_164157712900393.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,340 F1 · security: On June 11, 2021, the holder was granted 93,371 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021. These RSUs vested in their entirety on December 31, 2021. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 14:09 UTC |
Macias William L.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 167,325 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001764013-21-000121 · wf-form4_163648493233700.xml · derivative · entry 2 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,325 Underlying: Common Stock · 167,325 shares Expires 2031-11-05 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 25, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 14:09 UTC |
Macias William L.Chief Medical Officer
|
GrantCommon Stock | 112,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-21-000121 · wf-form4_163648493233700.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,153 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest in their entirety on January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of such date. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 21:11 UTC |
Barnett Eva ReneeChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 333,000 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001764013-21-000108 · wf-form4_163459145674723.xml · derivative · entry 2 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,000 Underlying: Common Stock · 333,000 shares Expires 2031-10-15 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 4, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 21:11 UTC |
Barnett Eva ReneeChief Financial Officer
|
GrantCommon Stock | 143,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-21-000108 · wf-form4_163459145674723.xml · nonDerivative · entry 1 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,500 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on October 4, 2022 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 16:07 UTC |
Barnett Eva ReneeChief Financial Officer
|
GrantCommon Stock | 59,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-21-000106 · wf-form4_163345002882992.xml · nonDerivative · entry 1 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,500 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest in their entirety on January 1, 2022, subject to the Reporting Person providing continuous service to the Issuer as of such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 19:59 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 464,700 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 4 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 464,700 shares Expires 2031-03-19 F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 19:59 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 464,700 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 3 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,700 Underlying: Common Stock · 464,700 shares Expires 2031-03-19 F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 19:59 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 430,700 | $0.00 Strike: $19.01 | $0.00 |
DisclosureSEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 2 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 430,700 shares Expires 2030-05-14 F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 19:59 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 430,700 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,700 Underlying: Common Stock · 430,700 shares Expires 2030-05-14 F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 20:02 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 191,100 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 4 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 191,100 shares Expires 2031-03-19 F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 20:02 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
GrantStock Option (right to buy) · Derivative | 191,100 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 3 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,100 Underlying: Common Stock · 191,100 shares Expires 2031-03-19 F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 20:02 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 319,700 | $0.00 Strike: $19.01 | $0.00 |
DisclosureSEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 2 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 319,700 shares Expires 2030-05-14 F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 14, 2021 20:02 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
GrantStock Option (right to buy) · Derivative | 319,700 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,700 Underlying: Common Stock · 319,700 shares Expires 2030-05-14 F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 16, 2021 17:15 UTC |
Macias William L.Chief Medical Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 369,320 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001764013-21-000100 · wf-form4_163182692972092.xml · derivative · entry 2 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 369,320 shares Expires 2031-06-11 F1 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 13, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| September 11, 2021 Filed Sep 16, 2021 17:15 UTC |
Macias William L.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 369,320 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001764013-21-000100 · wf-form4_163182692972092.xml · derivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,320 Underlying: Common Stock · 369,320 shares Expires 2031-06-11 F1 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 13, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 13:08 UTC |
Hughes Douglas J.Director
|
PurchaseCommon Stock | 18,247 | $8.24 | $150,355.28 |
DisclosureSEC source: 0001764013-21-000092 · wf-form4_163032892005129.xml · nonDerivative · entry 1 Hughes Douglas J. · CIK 0001710863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,447 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.22 - $8.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 20, 2021 Filed Aug 20, 2021 22:14 UTC |
MIGAUSKY GEORGE VDirector
|
PurchaseCommon Stock | 7,000 | $7.65 | $53,550.00 |
DisclosureSEC source: 0001764013-21-000090 · wf-form4_162949763817516.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,200 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 - $7.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 21:29 UTC |
Pande AtulDirector
|
PurchaseCommon Stock | 5,000 | $7.98 | $39,900.00 |
DisclosureSEC source: 0001764013-21-000088 · wf-form4_162914934479727.xml · nonDerivative · entry 1 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Purchased through Trust Owned by Atul Pande and his Spouse Disclosed balance after: 45,200 Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 18:12 UTC |
Fromkin Andrew J.Director
|
PurchaseCommon Stock | 5,500 | $7.90 | $43,450.00 |
DisclosureSEC source: 0001764013-21-000081 · wf-form4_162870554557188.xml · nonDerivative · entry 1 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,700 Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 20:10 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
GrantCommon Stock | 285,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-21-000069 · wf-form4_162810780822330.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,806 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: 50% of the RSUs will vest on January 1, 2022 and the remainder of the RSUs will vest on January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.